Chemosensitivity to agents such as cisplatin, gemcitabine and carboplatin was increased when used in combination with the WEE1 inhibitor MK-1775 (otherwise called AZD1775) with tumor growth being reduced in many cancer types; importantly, no additional toxicity beyond that seen with the DNA damaging agents alone was seen [46]. The gene discussed is WEE1; the disease is cancer.